T he mechanistic target of rapamycin (mTOR, MTOR) regulates cell growth and metabolism through its activity as a serine-threonine kinase. MTOR forms two protein complexes, mTORC1 and mTORC2, which are involved in phosphorylating many downstream targets, including S6K, 4EBP1, and AKT (1, 2) . Rapamycin and its analogs inhibit mTOR activity, are widely used as immunosuppressants during organ transplantation, and have been increasingly used to prevent graft-versushost disease after bone marrow transplantation (3) . mTOR inhibition is pleiotropic, having differential effects on various immunocompetent cells (4) (5) (6) . Many studies focused on proliferation/ activity of dendritic and T cell populations as the primary targets of immunosuppression (3, 7, 8) . In this study, we chose to focus on B cells. We recently developed a potential mouse model of chronic immunosuppression by transcriptionally inactivating a knock-in (KI) allele of mTOR; spleens of these hypomorphs were disproportionately small relative to their total body weight, and mTOR protein levels were reduced by 70%. Unexpectedly, we found several effects of this KI on B cell differentiation, migration, and homeostasis, in addition to increases in induced Foxp3 + T regulatory cells (9) . Similarly, rapamycin was also shown to promote the expansion of Foxp3 + regulatory T cells after organ transplantation (10) . In KI mice, B cell proliferation was less impaired in response to LPS than to either anti-IgM or anti-CD40, suggesting that innate immune responses of the mTOR-deficient mice were more intact than were their adaptive responses (9) .
In this study, we examined the humoral immune responses of mTOR KI mice to infection with Streptococcus pneumoniae, one of the most common bacterial infections arising, as a result of immunosuppression, in both marrow and solid organ transplant patients (11, 12) , as well as in patients undergoing chemotherapy (13) . Mediation of infection requires the formation of germinal centers (GCs) within splenic follicles as an essential event in the generation of high-affinity, Ab-secreting plasma cells and memory B cells (14, 15) . In this study, GC formation and GC B cell functions were compared between mTOR hypomorphs (KI) and wildtype (WT) littermates, as were their ability to produce high-affinity Ab isotypes in response to the model T cell-dependent Ag 4-hydroxy-3-nitrophenylacetyl hapten (NP) conjugated to chicken g globulin lysine (NP-CGG) or S. pneumoniae infection. In addition, to address the role of mTOR in B cells in these responses, we examined the humoral responses of conditional B cell knockout (KO) of mTOR [mTOR-floxed hypomorphs were crossed to CD19 cre mice (16) ] immunized with NP-CGG. Ig somatic hypermutation (SHM) and class-switch recombination (CSR) are the primary effectors of Ab diversity and occur following stimulation of mature B cells by a cognate Ag within the GCs of peripheral lymphoid organs. SHM and CSR initiation requires activation-induced cytidine deaminase (Aicda; AID), which deaminates cytidine residues in DNA to produce uracil, thus generating U:G mismatches (17) (18) (19) . SHM introduces point mutations into H chain Ig genes, effectively producing Abs with varying avidities for a given Ag, thereby increasing Ab diversity (20) (21) (22) . CSR is an additional mechanism of Ab diversification by which switch regions within IgH genes rearrange to express downstream constant regions corresponding to different Ig Ab classes (23) (24) (25) ; CSR is dependent upon cell division (26, 27) . Because CSR and SHM are obligatory for the production of high-affinity Abs, we performed both in vivo and ex vivo experiments to determine whether these mechanisms are intact in our mTOR KI and KO mice.
Materials and Methods

Mice
Mice were bred in conventional facilities with food and water ad libitum. All animals were treated in accordance with the guidelines provided by the Animal Care and Use Committee of the National Cancer Institute for protocol numbers LG-009, LG-017, and LG-023. mTOR KI offspring carrying neo-mTOR (mTOR KI) were identified by PCR of tail DNA using forward (59-CCTTGGCAGCTTTGAATTTGAAG-39) and reverse (59-CA-GAGACAGGAGACGAAGAACAGG-39) primers; 239-and 273-bp fragments were amplified from WT and KI mice, respectively, as described (9) . mTOR KI mice were bred with b-actin cre mice; the resultant progeny deleted neo ubiquitously while retaining the BALB/c allele of mTOR. These KI neo 2/2 mice have the same amount of mTOR protein and make similar amounts of IgG Ab in response to Ag as do WT mice (9) . Conditional B cell KO mice (mTOR KO) were generated by crossing CD19 cre mice (16) ). mTOR KO offspring carrying the mTOR deletion in CD19 + B cells were identified by PCR of tail DNA using forward (59-CAGCATCACTCTTG-CCCTTCGAACCCTTGG-39) and reverse (59-CCAGCCTCTTCTCTG-TTTCTACC-39) primers. WT (1342 bp), and excised allele (840 bp) fragments were amplified from WT and KO mice respectively (as described in Supplemental Fig. 1B) (9) . Spleen weights from mTOR KO mice adjusted for total body weight were similar to those of WT mice (Supplemental Fig. 1C ). AID KO (Aicda 2/2 ) mice backcrossed to BALB/c mice were originally obtained from Muramatsu et al. (19, 28) . AID KO mice and their WT littermates were aged in our conventional (non-SPF) facility to assess their survival. One group of 17 AID KO mice was weaned onto bacon-flavored chow containing the antibiotic metronidazole (138 mg/kg).
Reagents
Pneumococcal surface protein A (PspA) was purified as described (29) . LPS and rapamycin were purchased from Sigma-Aldrich. a-d-dextran was purchased from Fina BioSolutions. Recombinant mouse IL-4 was purchased from PeproTech.
Immunizations
Mice (8-10 wk old) were immunized i.p. with 2 3 10 8 CFU heat-killed S. pneumoniae capsular type 14 protein (Pn14) (29) in saline or 100 mg NP 58 -CGG (Biosearch Technologies; catalog no. N-5055) adsorbed on 25 mg alum (Rehydragel HPA; Reheis). Control mice were injected with the same volume of saline. Mice injected with Pn14 were boosted 14 d after the first injection with 2 3 10 8 CFU/mouse. Measurements of anti-NP and antiPspA Ig isotype titers were determined from sera of mice.
Preparation and infection of Pn14
A frozen stock of Pn14 was thawed and plated on trypticase soy agar plus 5% sheep blood (TSA II; BD Diagnostic Systems) for a 24-h incubation at 37˚C under anaerobic conditions (BD BBL GasPak Plus Anaerobic System Envelopes with Palladium Catalyst); the isolated colonies were transferred to 15 ml Bacto-Todd Hewitt Broth (BD Diagnostic Systems) for 18 h without oxygen or shaking. Pn14 challenge titers were determined by 10-fold serial dilution and plating onto the blood agar. Three-month-old mice were challenged with ∼1-5 3 10 6 CFU/mouse of live Pn14 in a final volume of 200 ml PBS by i.p. injection. Fourteen days postbacterial immunization, mice were bled to determine Ab titers. On day 15, the mice were rechallenged i.p. with a high dose (1 3 10 8 CFU/mouse) of live Pn14; they were bled at 15 h postchallenge to determine bacteremia levels. Survival was monitored for 15 additional days.
Measurement of serum Ag-specific Ig isotype titers and avidities
Serum samples were prepared at a 1/50,000 dilution for total IgG or at a 1/ 10,000 dilution for total IgM. Quantification of IgG and IgM was performed by ELISA, according to the manufacturer's protocols (Immunology Consultants Laboratory Mouse IgG ELISA: E-90G and Mouse IgM ELISA: E-90M).
ELISA plates (Dynex Immulon 4HBX) were coated with 5 mg/ml (50 ml/ well) PspA or 10 mg/ml (50 ml/well) NP 58 -BSA (Biosearch Technologies; cat. no. 5050-10) in PBS overnight at 4˚C. Plates were blocked with PBS plus 1% BSA for 1 h at 37˚C. Two-fold dilutions of serum samples, starting at a 1/200 serum dilution, in PBS plus 0.5% BSA were added for 1 h at 37˚C, and plates were washed three times with PBS plus 0.1% Tween 20. Alkaline phosphatase-conjugated polyclonal rat anti-mouse IgM and IgG isotypespecific Abs (Southern Biotech) were added and incubated at 37˚C for 1 h. Plates were washed three times with PBS plus 0.1% Tween 20. Substrate (p-nitrophenyl phosphate, disodium; Sigma-Aldrich), at 1 mg/ml in 0.1 M glycine buffer (2 mM MgCl 2 , 1 mM ZnCl 2 [pH 10.4]), was added for 30 min at room temperature for color development. Color was read at an absorbance of 405 nm on a FLUOstar Omega plate reader.
Avidity of anti-PspA Abs was determined by modifying this immunoassay to include an 8-min wash with 6.5 M urea (30) . The percentage of avidity was calculated by dividing the OD of the urea-washed samples by the OD of the samples not washed with urea to obtain the percentage of IgG bound after washing. The relative affinities of anti-NP Abs were determined using an ELISA with BSA coupled to NP 4 -BSA and NP 14 -BSA. The relative affinity of the Abs was determined by the level of Abs using NP 4 -BSA, which measures only high-affinity anti-NP 4 -BSA, and NP 14 -BSA, which measures both high-and low-affinity anti-NP 14 (31) .
Immunohistochemical labeling
Slides of spleen sections (prepared by Histoserv) were first deparaffinized in xylene and rehydrated through a graded ethanol series. The slides were blocked for endogenous peroxidase with freshly prepared 30% H 2 O 2 in methanol and blocked with 10% normal rat serum in 0.1% BSA in PBS. Slides were incubated with either biotin-labeled anti-CD45R/B220 (BD Bioscience) or biotinylated peanut agglutinin (PNA) (Vector Laboratories), washed, and subsequently incubated with peroxidase-conjugated avidinbiotin complex mix and DAB Chromogen buffer (Vector Laboratories). Finally, the slides were counterstained with Hematoxylin Nuclear Counterstain (Vector Laboratories) and dehydrated. The procedure of double immunolabeling with anti-CD3 (labeled with avidin-biotin complex conjugated with alkaline phosphatase, developed with VECTOR Blue Chromogen; AbD Serotec) and anti-B220 (BD Bioscience) was similar and was performed by the Laboratory Animal Sciences Program, Science Applications International Corporation-Frederick, National Cancer InstituteFrederick. Stained slides were scanned, and GC area and number were measured using color deconvolution analysis software (Aperio Technologies, Vista, CA).
Cell purifications
CD43
2 B cells were purified from spleens using MACS kits (Miltenyi Biotec) following the removal of RBCs with ACK lysis buffer. Cells were cultured in RPMI 1640 supplemented with 10% FBS, penicillin (100 U/ ml), streptomycin (100 mg/ml), 1% L-glutamine, and 2-ME (5 3 10 25 M) (B cell culture media). WST-1 reagent (Roche 1644807) was used to measure cell viability/proliferation. 
SHM analysis
B cells were prepared from spleen or LNs, and RBCs were removed with ACK lysis buffer. GC cells from immunized mice were sorted using GL7 (FITC), FAS (PE), and B220 (allophycocyanin) (FACSDiva flow cytometer cell sorter). GC sorted cells (∼50,000 cells) were resuspended in 50 ml lysis buffer (10 mM Tris, 0.1 mM EDTA, and 0.5 mg/ml proteinase K) and incubated at 50˚C for 2.5 h and then protease K was inactivated at 95˚C for 10 min. The Ig-J H 4 intronic region was amplified with primers V1: 59-AG-CCTGACATCTGAGGAC-39 and V2: 59-TAGTGTGGAACATTCCTCAC-39 using 20 ml digested cell solution in a 50-ml reaction for the first-round PCR. The region was amplified in the second-round PCR using 5 ml reaction The data were analyzed with the Web-based SHMTool (32). Mutations were counted by two methods to provide a more accurate estimate of point mutation frequency (Table I) . A single B cell clone produces individual descendants, each with a variant sequence that can potentially share common mutations with sequences from other members of the clone. This redundancy, which leads to an overestimate of mutation frequency, was corrected by counting mutations involving the same nucleotide change and position only once, therefore providing an underestimate of mutation frequency (as described in Ref. 33 ). Thus, when comparing sequences, "nonunique" describes the mutations that are counted individually, regardless of commonality with other mutations in other sequences, and "unique" describes the mutations occurring at the same site and with the same nucleotide, thus grouped and counted only once (Table I ) (SHMTool). WT and KI sequences were compared separately. The actual mutation frequency for either WT or KI lies between the extremes of the two methods [ (33); SHMTool].
CSR analysis
CD43
2 resting B cells were obtained from spleens and LNs using magnetic CD43 beads; CD19 + CD43 2 resting B cells were further purified from CD43
2 cells using magnetic CD19 + beads, according to the manufacturer's instructions (Miltenyi Biotec). The cells (0.5 3 10 6 /well) were cultured in six-well plates in 5 ml B cell culture medium and incubated at 37˚C for 72 h. To induce specific isotype switching, B cells were stimulated with 50 mg/ml LPS (Sigma-Aldrich; L2880-25MG) plus either 20 ng/ ml IL-4 (PeproTech; 214-14) for induction of IgG 1 switching or 3 ng/ml a-d-dextran for induction of IgG 3 switching.
RNA preparation and real-time RT-PCR
Total RNA was isolated from cells with TRIzol reagent (Invitrogen). cDNAs were made with TaqMan Reverse Transcription Reagents (Applied Biosystems; cat. no. N8080234), and real-time PCR was performed using 
Western blot analysis
Protein extracts from tissues and cultured cells were prepared with lysis buffer ( 
Retroviral transduction of B cells
Retroviruses expressing AID-GFP or GFP were prepared by adapting previously described methods (34) in the following manner: PlatE cells were transfected with pMYs-mAID-IRES-EGFP or pMYs-IRES-EGFP plasmid by Lipofectamine 2000 (Invitrogen), and recombinant retrovirus was collected 24-36 h after transfection. The CD43 2 resting B cells isolated from spleens of WT or KI mice were preactivated for 24 h with 0.5 mg/ml anti-CD180 and transduced twice with retroviruses by spin inoculation (650 3 g for 90 min). Cells were cultured for an additional 3 d with 50 mg/ml LPS, 20 ng/ml IL-4, and 0.5 mg/ml anti-CD180 before being analyzed for IgG 1 cell surface expression by FACS.
Results
GC formation is affected by mTOR expression
To evaluate the effects of reduced mTOR on GC formation, mTOR KI mice were either primed with NP-CGG or primed and subsequently boosted with intact heat-killed Pn14, as described previously (9, 29) . GCs were evaluated 14 and 21 d postpriming with NP-CGG and Pn14, respectively, using immunohistochemical (IHC) staining and analysis of cell surface markers by flow cytometry. The average number of GCs in spleens of KI mice was 3-5-fold lower than in WT spleens (Fig. 1A, Supplemental Fig.  2A ). Furthermore, both the percentage of GC cells within the splenic section and the composite GC area relative to the total area of B cell lymphoid follicles were reduced disproportionately in KI mice (Fig. 1A, Supplemental Fig. 2A) (Fig. 1B, Supplemental Fig. 2B ). In contrast, the splenic and LN populations of CD11c + , CD21/35 + cells were similar between WT and KI mice that had received a prime/boost of Pn14 (Supplemental Fig. 3A ). In addition, CD3 + T cells were abundant in the lymphoid follicles of both WT and KI mice (Supplemental Fig. 3B ).
Reduced mTOR impairs IgG Ab-affinity maturation KI and WT mice were given priming doses of either NP-CGG or prime/boost doses of heat-killed Pn14 to assess their ability to mount humoral responses to Ags. Primary and secondary Agspecific Ab titers were measured against NP or PspA, as described (9, 29, respectively). In these experiments, anti-NP and anti-PspA IgG Ab titers were lower in KI mice 14 and 21 d postreceipt of priming doses (Fig. 1C, Supplemental Fig. 2C, 2D ). More specifically, the diminished capacity for generating PspAspecific IgG-isotype responses remained low a week after the boost immunization with S. pneumoniae, with the greatest deficits in IgG 1 and IgG 3 (6-and 10-fold, respectively) (Supplemental Fig.  2D ). Thus, constitutive reductions in mTOR expression caused deficits in specific Ab production that persisted even after secondary exposure to Ag.
To explore whether mTOR hypomorphic KI mice produce highaffinity Abs, the avidity of the anti-NP Abs was measured using the protocol described by Yamamoto et al. (31) , and KI mice developed lower Ag affinity Abs compared with WT littermates (Fig.  1D) . The anti-PspA IgG Abs were measured using a modified ELISA protocol (35) in which only higher-affinity Abs remained bound to PspA-coated microtiter plates after washing with 6.5 M urea. mTOR KI mice did not produce detectable amounts of highaffinity IgG to PspA until after the boost, whereas WT mice had readily measurable amounts as early as 1 wk following the initial immunization (Supplemental Fig. 2E ). Although the boost induced some high-affinity Abs in KI mice, the degree of affinity maturation continued to lag behind that of WT mice (Supplemental Fig. 2E ). Thus, mTOR can regulate Ab maturation to antigenic challenge in response to either intact or haptenated Ags. mTOR hypomorphic mice are more sensitive to live S. pneumoniae challenge Protection against S. pneumoniae relies not only on innate immune responses, it also requires an intact adaptive response (36) . To determine whether mTOR plays a role in mediating infection and to assess whether impaired Ab responses in mTOR KI mice might be biologically relevant, mice were challenged with a low dose (10 6 CFU) of live, encapsulated Pn14 and were rechallenged after 14 d with a high dose (10 8 CFU) and followed for 15 d. Ab titers to PspA 14 d after the initial challenge, but before the high-dose challenge, were considerably lower in mTOR KI mice than in WT mice ( Fig. 2A) . At 15 h postchallenge with 10 8 CFU, only 1 of 9 KI mice was bacteria-free compared with 5 of 10 WT mice; for the mice with detectable bacteremia at that time point, the average titer was slightly higher in KI mice (Fig. 2B) . All of the WT mice survived the high-dose challenge, whereas only 60% of the KI mice survived (Fig. 2C) .
Constitutive reductions in mTOR impair SHM
The lack of high-affinity Ab responses in mTOR KI mice led us to hypothesize that the frequency of SHM, a driver of Ab diversity, may be reduced in KI GC B cells. To address this question, SHM frequency was measured in mice immunized with NP-CGG. We analyzed the IgH J H 4-intronic sequence downstream of the rearranged VDJ region in GC B cells (B220 + GL7 + Fas + ) sorted from splenocytes of NP-CGG-immunized KI and WT mice. The frequency of SHM and pattern of point mutations were analyzed using SHMTool (32) . The frequency of SHM was decreased in GC B cells from KI mice compared with WT littermates (Fig. 2D , Table I ). The nonunique mutation frequency/total sequences (per 100 bp) was 0.52 in WT J H 4 introns and 0.32 in KI J H 4 introns (p , 0.001, Table I ). These findings held true for the total number of unique point mutations as well (Table I) . Overall, the reduction in mutation frequency was due primarily to a paucity of mutated sequences in mTOR KI mice (Fig. 2D) ; 37% of sequences from KI splenic GC B cells were not mutated, whereas only 17% of sequences from WT cells fell in this category, representing a .2-fold decrease in mutated J H 4 sequences in KI B cells (Fig. 2D) . Furthermore, although 6% of WT splenic GC B cell sequences had six mutations, none of the KI J H 4 intron sequences had as many mutations (Fig. 2D) .
The pattern of SHM point mutations was skewed in GC B cells from KI mice compared with WT mice (Table II) . The percentage of transversions from G to T or A to C was decreased for KI GC B cells (p , 0.05). Of the unique mutations, there were fewer G-T and C-A (12.5%) or T-G and A-C (15.4%) transversions in KI B cells compared with WT cells (26.1 and 25%, respectively) (Table II) . Additionally, KI B cells had more (59.4%) transitions from G to A and C to T compared with WT cells (43.5%) (Table  II) . Overall, there were fewer transversions and an increase in transitions seen in the mTOR-deficient mice.
mTOR KI mice have fewer mutations in Sm sequences and defective Ig class switching to IgG 1 ex vivo
The inability of mTOR KI mice to mount high-affinity IgG responses led us to ask whether their B cells were impaired in their ability to undergo CSR. Class switching occurs by intrachromosomal deletion recombination within switch regions upstream (Fig. 3A) , suggesting that the decreases in IgG Ab production may be due to defective CSR in mTOR KI cells. CSR has been linked to rates of B cell division (26, 27) . Proliferation rates of B cells expressing IgG 1 in KI mice were lower (Fig. 3B) , probably resulting from cells undergoing G 1 arrest (Supplemental Fig. 4A ) rather than apoptosis, because similar numbers of cells underwent apoptosis in KI and WT mice (Supplemental Fig. 4B ). Analysis of CFSE staining over the course of at least four cell cycle divisions (Fig. 3B) indicated that the percentage of cells within each cell cycle that switched to IgG 1 expression was lower in the first and second cell divisions, with this difference persisting through the fourth division, likely because fewer cells entered successive divisions (Fig. 3B) . These results imply that IgG 1 class switch was less efficient in mTOR KI B cells.
To further evaluate deficits in IgG switching in KI mice, the germline (preswitch) and postswitch transcripts for IgG 1 and IgG 3 were measured by PCR (protocol adapted from Ref. 19 ). These analyses confirmed that KI mice had no change in levels of germline m, g1, and g3 transcripts but had lower levels of postswitch g1 and g3 transcripts (Supplemental Fig. 4C, 4D) .
Independent evaluation of the role of mTOR in CSR was gained by treating resting B cells from WT mice with rapamycin, which preferentially inhibits mTORC1 and inhibits mTORC2 usually only after long-term treatment and in a cell type-specific manner (42) . IgG 1 switching (Fig. 3C ) was impaired in WT activated CD43
2 splenic B cells treated with low-dose rapamycin (0.1 nM), which had modest effects on cell viability and proliferation until the fifth cell division where KI cells were diminished with respect to WT (Fig. 3D) , cell cycle arrest (Fig. 3E ), or apoptosis (Fig. 3F) . Together, these findings confirm that mTOR can affect CSR through its effect on cell division/proliferation, but they also suggest a possible role independent of proliferation.
Levels of CSR/SHM-associated proteins are lower in mTOR KI mice
A number of DNA damage response/repair proteins, in addition to AID and UNG, are involved in SHM/CSR activities (24, 25) . RT-PCR experiments using LPS-stimulated B220 + cells examined the ratio of KI/WT mRNA levels for several genes implicated in CSR/ SHM activity (Aicda, Ung, Pol h [PolH], Exo1, Msh2, and Msh6) in splenic B220 + cells. Following LPS stimulation, B220 + KI splenocytes were deficient only in Aicda (AID) mRNA levels relative to WT (Fig. 4A) . AID protein levels were confirmed to be decreased in LPS-stimulated mTOR KI splenocytes relative to WT (Fig. 4B) .
Nuclear AID levels are low in mTOR KI cells AID expression can be affected by both forkhead transcription factors and the chaperone protein HSP90 (43, 44) . Retroviral gene- transfer studies (45, 46) showed that constitutively active AKT in B cells can inactivate forkhead transcription factor FOXO1, resulting in concomitant decreases in AID and suppression of CSR; in addition, phosphorylation of AKT at Ser 473 is required for phosphorylation of FOXO1/3a (47) . In our earlier study (9) , LPSstimulated B cells from mTOR KI mice had increased levels of pAKT Ser473 , and, in the current study, we showed that B cells from mTOR KI mice have increased levels of pAKT Ser473 and pFOX-O1 Thr24 , concomitant with lower levels of AID in response to LPS and IL-4 (Fig. 4B) . Recent studies also showed that HSP90 can stabilize levels of AID in the cytoplasm and the nucleus (44) . In contrast to cytoplasmic fractions, nuclear extracts from mTOR KI B cells stimulated with LPS and IL-4 had much lower levels of HSP90 and AID compared with WT B cells (Fig.  4C) . Thus, lower AID protein levels in mTOR KI B cells may result from increases in phospho-AKT and phospho-FOXO, in addition to reductions in nuclear HSP90.
Increasing AID expression rescues IgG 1 switching in mTOR KI B cells AID expression levels are directly proportional to the extent of CSR and SHM (41, 48) . To determine whether reintroduction of AID protein into mTOR hypomorphic KI cells could restore IgG 1 switching, CD43 2 resting B cells were isolated from KI and WT mice, transduced with either GFP or AID-GFP retroviruses, and then stimulated with LPS and IL-4. As expected, introduction of the control GFP retrovirus expressing only GFP in KI resting B cells did not restore IgG 1 switching to those levels seen in WT B cells, nor did GFP alone affect switching in AID KO B cells used as a control (Fig. 4D) . When AID levels were increased in KI mice by the AID-GFP retrovirus, IgG 1 switching was comparable between WT and KI cells and similar to AID KO cells transduced with the AID-GFP retrovirus (Fig. 4D) . These data continue to support a role for mTOR in controlling AID levels.
Survival is increased in AID KO mice housed in filter-top cages and treated with antibiotics AID KO mice are known to experience a 100-fold expansion of anaerobic flora in their small intestine (49), and we experienced difficulty in maintaining a healthy population of these mice in a conventional (non-SPF) colony. As a result, we monitored the overall survival of AID KO mice and their WT littermates, with and without metronidazole, housed in a conventional facility over the course of ∼2 y (Supplemental Fig. 4D ). WT mice lived longer (∼780 d) than did AID KO mice (240-360 d) (log-rank [MantelCox] x 2 = 19.1, p , 0.0001). Furthermore, AID KO mice that were given feed containing the antibiotic and antiprotozoal, metronidazole, and housed in autoclaved, filter-topped cages lived longer (∼360 d) than did conventionally maintained AID KO mice (∼240 d) (log-rank [Mantel-Cox] x 2 = 6.51, p , 0.01).
B cell-specific mTOR KO mice are impaired in their GC responses
Because mTOR levels were constitutively reduced in all cell types from birth in the mTOR (KI) hypomorphs, we sought to determine whether mice deleted for mTOR specifically in their B cell lineage (mTOR KO mice: mTOR fl/fl CD19 Cre/+ ) (Supplemental Fig. 1A ) would exhibit similar defects in GC formation and Ab production. We did not find differences in B cell subpopulations in the bone marrow (Supplemental Fig. 1D ) or in the transitional T1 B cell subpopulation in the spleens (Fig. 5A ) between KO and WT (mTOR +/+ CD19 Cre/+ ) mice. In contrast, CD19 + , mature, transitional T2 and marginal zone (Fig. 5 ) B cell populations were lower in spleens of KO mice compared with WT mice. Reductions in B cell populations in LNs were also seen in mTOR KO mice (Fig.  5) . Similar to results obtained in mTOR KI mice, fewer GCs, as assessed by IHC (Fig. 6A ) and flow cytometry (Fig. 6B) , formed in spleens of KO mice immunized with one dose of NP-CGG. These mTOR KO mice also produced fewer IgG isotypic Abs, with the exception of IgG2a (Fig. 6C) , and fewer high-affinity anti-NP Abs (Fig. 6D ) compared with their WT littermates. Resting B cells, stimulated with LPS and IL-4, from the mTOR KO mice exhibited lower rates of CSR in ex vivo cultures (Fig.  6E) . Furthermore, we confirmed that B cells from mTOR KO mice, similar to their hypomorphic (KI) counterparts, have increased levels of pAKT Ser473 and pFOXO1 Thr24 concomitant with lower levels of AID (Fig. 6F ) in response to LPS and IL-4. Thus, these experiments confirm that mTOR deletion in CD19 + cells alone can negatively affect GC formation, Ab production, CSR, and establishment of B cell populations in the periphery.
Discussion
mTOR controls cell growth and is often dysregulated in several diseases, including cancer and immunosuppressive diseases (1, 2) . Rapamycin analogs, specific inhibitors of mTOR kinase activity, have been used in the transplant setting to induce chronic immunosuppression to prevent rejection and graft-versus-host disease (3, 11) . Long-term survivors of organ and bone marrow transplantation are at increased risk for infections, particularly from encapsulated bacteria, such as S. pneumoniae, which accounts for ∼30% of community-acquired pneumonia and is known to be a common infection in immunosuppressed individuals (11) (12) (13) .
We recently showed that constitutive reductions in mouse mTOR gene expression are associated with a partial block in B cell development in the bone marrow, altered percentages of various B cell populations in the spleen, and smaller spleens (9) . We now report that B cell-specific reductions in mTOR impair GC formation, decrease the production of IgG isotypes in response to immunization, and lead to a decrease in affinity maturation of Abs in vivo. Remarkably, when challenged with an infection that elicits an Ab response, 40% of mTOR hypomorphic mice died compared with none of the WT counterparts. Therefore, these mTOR hypomorphic KI mice serve as a novel and clinically relevant model to evaluate infection in the presence of chronic immunosuppression.
The two processes, SHM and CSR, contributing to Ab gene diversity in mammalian cells were decreased in activated mTOR KI B cells. SHM patterns in KI mice were distinct from WT mice; there were more transitions from G-A to C-T bp and fewer transversions (G/T; C/A and A/C; T/G) in KI B cells. Maul and Gearhart (18) described two potential pathways for processing U: G mismatches that are both initiated by AID activity. Specifically, mutations at the G-C base pair use UNG, APE, and the lowfidelity polymerase Rev1, whereas mutations at the A-T base pair use the MSH2-MSH6 heterodimer, exonuclease 1, and the errorprone polymerase Pol-h (18). Our findings in mTOR KI mice were consistent with lower Ung/UNG expression but no significant change in Msh2/6. In addition, defects in KI B cells were further documented by ex vivo experiments demonstrating lower Sm mutation and CSR frequencies in response to IL-4 and LPS. Lower IgG1 CSR frequencies were also observed in B cell-specific KOs of mTOR.
The ability of differential mTOR expression to affect SHM and CSR represents a new immunoregulatory role for mTOR. The results seen in mTOR hypomorphic KI mice were similar to those obtained in AID haploinsufficient (AID +/2 ) mice; these mice also have impaired CSR and reductions in both SHM and Ab-affinity maturation (41, 48) . Takizawa et al. (41) suggested that AID protein content may fall below a critical threshold in AID +/2 B cells, potentially through mechanisms controlling nuclear AID or as a result of compromised AID activity because of lower AID transcription.
Reduced AID levels in both our KI and B cell-specific KO mice, particularly the lower AID levels seen in nuclear extracts from Reductions in CSR/SHM and Ab-affinity maturation ultimately affect Ab diversification, which can interfere with the ability of the immune system to respond to microbial challenge and recognize specific Ags. Indeed, under conventional conditions, the survival of AID KO mice was much lower than that of their WT littermates; prophylactic antibiotic treatment of AID KO mice increased their survival.
Our studies suggest that suppression of AID activity via rapamycin may contribute to the impairment of humoral immune responses and provide further rationale for potential immunization against microbial agents prior to immunosuppressive treatment. Immunizations have typically been given simultaneous with or after cessation of immunosuppressive drugs (50, 51). The improved survival of AID KO mice treated prophylactically with antibiotics suggests that the coadministration of antibiotics with rapamycin might decrease the risk for opportunistic streptococcal infections. In addition, these findings may have relevance in other settings, specifically the use of mTOR inhibitors as anticancer agents (2) . In this situation, increased AID was shown to promote both tumor progression (41, (52) (53) (54) (55) and drug resistance (56) . Our studies confirmed that mTOR inhibition can downregulate AID as reported, perhaps by the phosphorylation of both AKT and FOXO proteins and the amount of nuclear HSP90 (43) . Thus, fine-tuning mTOR inhibitors with appropriate dosing regimens may help to restore normal AID levels or activities needed for the establishment of GC reactions and genesis of high-affinity Abs while effectively regulating the AID mutator phenotype during tumor progression and/or drug resistance. Bliskovsky, Kaori Sakakibara, and anonymous reviewers for comments on the manuscript. We thank Alexander Kovalchuk for advice on SHM sequence analysis and Makiko Takizawa for cloning AID-coding sequences into the pMYs-IRES-GFP vector. We also thank Stefan Kuchen-Brandes and Arito Yamane for advice and assistance with AID rescue experiments. AID KO mice were kindly provided by Michael Potter.
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